SCHEMBL6178331

SCHEMBL6178331

COc1ccc(-c2cnccc2C(C)C2(C(C)c3ccncc3-c3ccc(OC)cc3)NC(=O)N(c3ccc(SC(F)(F)F)cc3)C2=O)cc1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.41
GAA P10253 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
ALDH1A1 P00352 1/20 0.41
SLC22A12 Q96S37 3/20 0.39
IGF1R P08069 6/20 0.38
MAPT P10636 2/20 0.34
CCNE2 O96020 1/20 0.34
CDK4 P11802 1/20 0.34
CCND1 P24385 1/20 0.34
CCNE1 P24864 1/20 0.34
CDK2 P24941 1/20 0.34
CACNA1B Q00975 1/20 0.34
RPS6KA3 P51812 1/20 0.32
THRB P10828 1/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173832 0.89 IGF1R (0.40) ALDH1A1SLC22A12IGF1RLMNA
SCHEMBL6174506 0.89 CYP3A4 (0.43) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6173005 0.85 CYP3A4 (0.43) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6173549 0.82 IGF1R (0.43) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6174921 0.82 IGF1R (0.43) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6174310 0.82 IGF1R (0.43) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6171727 0.81 HSD11B1 (0.36) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6173913 0.81 IGF1R (0.43) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6173174 0.81 IGF1R (0.44) ALDH1A1IGF1R
SCHEMBL6174587 0.81 MAPT (0.37) CYP3A4GAACYP2C9CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed